OXY'PHARM

Serial Number 79208689
Registration 5582663
709

Registration Progress

Application Filed
Feb 13, 2017
Under Examination
Approved for Publication
Jul 31, 2018
Published for Opposition
Jul 31, 2018
Registered
Oct 16, 2018

Trademark Image

OXY'PHARM

Basic Information

Serial Number
79208689
Registration Number
5582663
Filing Date
February 13, 2017
Registration Date
October 16, 2018
Published for Opposition
July 31, 2018
Cancellation Date
May 2, 2025
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
709
Status Date
May 2, 2025

Rights Holder

OXY'PHARM

99
Address
917 rue Marcel Paul
F-94500 CHAMPIGNY-SUR-MARNE
FR

Ownership History

OXY'PHARM

Original Applicant
99
F-94500 CHAMPIGNY-SUR-MARNE FR

OXY'PHARM

Owner at Publication
99
F-94500 CHAMPIGNY-SUR-MARNE FR

OXY'PHARM

Original Registrant
99
F-94500 CHAMPIGNY-SUR-MARNE FR

Application History

37 events
Date Code Type Description Documents
May 2, 2025 C71T O CANCELLED SECTION 71 Loading...
Oct 16, 2023 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Feb 15, 2019 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jan 30, 2019 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jan 30, 2019 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jan 16, 2019 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Oct 16, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 31, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 31, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 27, 2018 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jul 11, 2018 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jul 11, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 11, 2018 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jun 20, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 20, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 20, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 20, 2018 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 20, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 1, 2018 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jan 1, 2018 GNFR O FINAL REFUSAL E-MAILED Loading...
Jan 1, 2018 CNFR R FINAL REFUSAL WRITTEN Loading...
Dec 9, 2017 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 9, 2017 ALIE A ASSIGNED TO LIE Loading...
Dec 9, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 6, 2017 ALIE A ASSIGNED TO LIE Loading...
Nov 28, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 28, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 28, 2017 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 8, 2017 RFNT P REFUSAL PROCESSED BY IB Loading...
Jun 16, 2017 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jun 16, 2017 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jun 7, 2017 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jun 6, 2017 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jun 6, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 2, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 2, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 1, 2017 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Additional Information

Design Mark
The mark consists of the wording "OXY'PHARM" in white except the letter "Y" which is orange, three droplets in light blue, orange and light green with white circular and oval designs within, all of the foregoing within a black rectangle.
Color Claim
The color(s) black; light blue; orange; light green and white is/are claimed as a feature of the mark.